NSCMID 2017 Meeting Scientific Programme

Tórshavn, Faroe Islands 31 August – 3 September 2017

 

Thursday 31 August

Mini Course – 16:30–18:30

TRAVEL MEDICINE & VACCINATIONS

Chair: Bjørn Blomberg, Norway, Anu Kantele, Finland, Hilmir Asgeirsson, Sweden & Carsten Schade Larsen, Denmark

 

Friday 1 September

Symposium 01 – 09:00–10:30

CPO, MCR1, NDM, ESBL, VRE ETC. – BEYOND THE ERA OF ANTIBIOTICS – THE ROLE OF INFECTION CONTROL AND ANTIBIOTIC STEWARDSHIP

Chairs: Anders Johansson, Sweden & Shahin Gaini, Faroe Islands

09:00–09:30
Post-antibiotic era – hype or real risk
Robert Leo Skov, Germany

09:30–10:00
Antibiotic stewardship – the Nordic experience
Håkan Hanberger, Sweden

10:00–10:30
Infection control – role in 2017 in an era of multi-resistant organisms
Hans Jørn Kolmos, Denmark

10:30–11:00
COFFEE BREAK, POSTER & EXHIBITION VIEWING

 

Symposium 02 – 11:00–12:00

UPDATE ON DIAGNOSTICS, RESISTANCE AND EPIDEMIOLOGY OF GRAM-NEGATIVE ORGANISMS

Chairs: Jan Egil Afset, Norway & Ulrik S Justesen, Denmark

11:00–11:30
Carbapenem and colistin resistance in Gram-negatives – mechanisms and epidemiology
Ørjan Samuelsen, Norway

11:30–12:00

Treatment options for carbapenemase-producing and colistin resistant Gram-negatives
Christian Giske, Sweden

 

Symposium 03 — 12:00–13:00

HIV IN THE ART ERA
Chairs: Court Pedersen, Denmark & Magnús Gottfredsson, Iceland

12:00–12:30
HIV in Europe - 2017. Status and challenges on individual and population based levels
Jens D Lundgren, Denmark

12:30–13:00
HIV cure - state of the art
Ole Søgaard, Denmark

 

13:00–14:00 LUNCH BREAK, POSTER & EXHIBITION VIEWING

 

Symposium 04 — 14:00–15:30

RARE INFECTIOUS DISEASE ENTITIES
Chairs: Sigurdur Skarphedinsson, Denmark & Tytti Vuorinen, Finland

14:00–14:30
Chlamydia psittaci and psittacosis - a thrilling story from the Faroe Islands
Bjørn Herrmann, Sweden

14:30–15:00
Tularemia ecology and epidemiology in the Nordic Countries
Anders Johansson, Sweden

15:00–15:30
When and how to look for usutu, zika and other dengue-like emerging viral diseases
Anders Fomsgaard, Denmark

 

15:30–16:00 COFFEE BREAK, POSTER & EXHIBITION VIEWING

 

HONORARY LECTURE – 16:00–16:45

Chairs: Peer B Christensen, Denmark & Páll Weihe, Faroe Islands

Progress toward the elimination of HBV
Brian J. McMahon, USA

 

WELCOME RECEPTION – 16:45–18:00

 

Saturday 2 September

General assembly (NSCMID members only) – 8:30–09:00

 

Symposium 05 – 09:00–10:30

HCV IN A NEW ERA OF TREATMENT SUCCESS

Chairs: Peer Bjerth Christensen, Denmark & Eran J McMahon, USA

09:00–09:30
Hepatitis C – state of the art
Heiner Wedemeyer, Germany

09:30–10:00
Hepatitis C – a global perspective
Olav Døhl, Norway

10:00–10:30
Treatment as prevention for hepatitis C in Iceland (TRAP HEP C) – a real world experience from a nationwide elimination program using direct acting antiviral agents
Magnús Gottfredsson, Iceland

10:30–11:00
COFFEE BREAK, POSTER & EXHIBITION VIEWING

 

Platinum Satellite Symposium – 11:00–12:30

Sponsored by AbbVie

ELIMINATION OF HCV: NORDIC PERSPECTIVES AND AMBITIONS

Chair: Nine Weis, Denmark

11:00–11:05
Welcome and introduction. Why HCV elimination as a goal?
Nine Weis, Denmark

11:05–11:20 — HCV in Denmark: Epidemiology and elements of a national strategy
Peter E. Christensen, Denmark

11:20–11:35 — Elimination of hepatitis C in Norway? Yes, we can
Olav Dalgard, Norway

11:35–11:50 — HCV elimination in Sweden: How to find patients is one of the burning questions
Anders Nystedt, Sweden

11:50–12:05 — Implementation of the National HCV Strategy in Finland
Salla K. Tolonen, Finland

12:05–12:20 — Panel discussion: Is it feasible to create a Nordic ambition for elimination of HCV? Opportunities and barriers
Moderated by Nina Weis, Denmark

12:25–12:30 — Closing remarks
Nina Weis, Denmark

12:30–13:30 — LUNCH BREAK, POSTER & EXHIBITION VIEWING

 

13:30–14:00 — Silver Light Symposium

Sponsored by BD
The need for speed in infection control
Bram MW Dieder, The Netherlands

14:00–15:30 — Symposium 06: MOLECULAR DIAGNOSTICS IN CLINICAL MICROBIOLOGY
Chairs: Andreas Mattsson, Sweden & Dahes H. Christiansen, Faroe Islands

14:00–14:30 — Rapid diagnostics and POCT: what will the future bring?
Jan Gorm Lisby, Denmark

14:30–15:00 — Whole genome sequencing: from local surveillance to nationwide surveillance
Henrik T. Westh, Denmark

15:00–15:30
Principles and current and future applications of mass-spectrometry in clinical microbiology and infectious diseases
Svein-Ole Mikalsen, Faroe Islands

 

15:30–16:00 COFFEE BREAK, POSTER & EXHIBITION VIEWING

 

Symposium 07 — 16:00–17:30

TUBERCULOSIS – STATUS 2017
Chairs: Arni K. Fjelstad, Finland &
Hilmur Asgeirsson, Sweden

16:00–16:30
Challenges in tuberculosis control in the Nordic area
Troels Lillebæk, Denmark

16:30–17:00
Can diagnosis of tuberculosis still be a challenge in a modern laboratory setting?
Kis S. Johansen, Denmark

17:00–17:30
Multidrug and extensively drug resistant tuberculosis in Europe
Christoph Lange, Germany

 

20:00 – CONGRESS DINNER AT HOTEL FØROYAR

 

Sunday 3 September

Symposium 08 — 08:45–10:00

YOUNG INVESTIGATOR PRESENTATIONS

Chairs: Carsten Schade Larsen, Denmark & Ingilbjørg Hammershø is cut off in the picture, so I can’t see the resti, Iceland

08:45–09:00
Congenital cytomegalovirus infection in Finland
Laura Puinikka, Finland, et al

09:00–09:15
Metabolomic analysis of sera from patients with community-acquired pneumonia
Alicia Edin, Sweden, et al.

09:15–09:30
Tir-domain proteins of nosocomial Enterococcus faecium interfere with TLR-2 signaling and enhance growth in blood
Thea Wagner, Norway, et al.

09:30–09:45
Pneumococcal carriage and antibacterial resistance and serotype prevalence from 2009 to 2016 in the Faroe Islands
Marita D Magnussen, Faroe Islands, et al.

09:45–10:00
Outpatient antibiotic consumption in Iceland: a 12-year population-based study
Elias S Eypórsson, Iceland, et al.

10:00–10:30 COFFEE BREAK & EXHIBITION VIEWING

 

Symposium 09 — 10:30–12:00

VECTOR BORNE DISEASES, CLIMATE CHANGES AND CIRCUMPOLAR INFECTIOUS DISEASES
Chairs: Sigurdur Gudmundsson, Iceland & Terho Heikkinen, Finland

10:30–11:00
Emerging vector borne diseases in Nordic Countries
Sigurdur Schierperdissen, Denmark

11:00–11:30
The risk of clinical disease or asymptomatic seroconversion in humans after a tick bite: the STING study. Presentation of the ScanTICK Innovation Project and the NSCMID TBD Working Group
Anna J Henningsson, Sweden

11:30–12:00
International circumpolar surveillance, an Arctic Network for the surveillance of infectious diseases
Michael Bruce, USA

12:00–12:10 CLOSING CEREMONY

Closing of NSCMID 2017 – 12:00–12:05
Shehin Gaini, Faroe Islands

Invitation to NSCMID 2018 – 12:05–12:10
Sigurður Guðmundsson, Iceland